Allyson Tighe is Co-founder and Associate at Amplitude Ventures, a healthcare and life sciences venture capital fund.
Allyson brings close to ten years of healthcare, life sciences and venture capital experience to the PHEMI Board. Prior to Amplitude, Allyson was an investor at BDC Healthcare Fund where she helped manage a $270 million fund investing in transformative Canadian healthcare and life science companies. Prior to BDC, Allyson was Business Development Manager for the Centre for Drug Research and Development.
Allyson holds a Bachelor in Science in Genetics and a Masters in Science in Physiology, both from Western University, and an MBA from the Richard Ivey School of Business.